Jain Global LLC Rhythm Pharmaceuticals, Inc. Transaction History

Jain Global LLC

$11.9 Billion
Q2 2025

A detailed history of Jain Global LLC transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Jain Global LLC holds 3,908 shares of RYTM stock, worth $388,494. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,908

Holding current value

$388,494

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2025 Aug 14, 2025	BUY	$46.95 - $68.11 $183,480 - $266,173	3,908 New	3,908 $246,000
Q4 2024 Feb 14, 2025	BUY	$46.91 - $67.33 $314,297 - $451,111	6,700 New	6,700 $375 Million

Others Institutions Holding RYTM

# of Institutions

273

Shares Held

68.4M

Call Options Held

438K

Put Options Held

185K

Perceptive Advisors LLC New York, NY

419M
Shares

$41.7 Billion
94.44% of portfolio
Black Rock Inc. New York, NY

6.74M
Shares

$670 Million
0.01% of portfolio
Ra Capital Management, L.P. Boston, MA

5.68M
Shares

$565 Million
9.85% of portfolio
Baker Bros. Advisors LP New York, NY

5.6M
Shares

$557 Million
4.61% of portfolio
Vanguard Group Inc Valley Forge, PA

5M
Shares

$497 Million
0.01% of portfolio

View Full List

About RHYTHM PHARMACEUTICALS, INC.

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $5.54B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

More about RYTM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jain Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jain Global LLC with notifications on news.

Account